Nurix Therapeutics, Inc. - Common stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | May 2026Filed 09/07/2026 | Feb 2026Filed 09/07/2026 | Aug 2025Filed 09/10/2025 | May 2025Filed 09/07/2026 | Feb 2025Filed 09/07/2026 | Aug 2024Filed 09/10/2025 | May 2024Filed 09/10/2025 | Feb 2024Filed 09/10/2025 |
|---|---|---|---|---|---|---|---|---|
| $9 | $6.3 | $7.9 | $44 | $18 | $13 | $12 | $17 | |
| −$90 | −$87 | −$86 | −$43 | −$56 | −$49 | −$45 | −$42 | |
| −$0.81 | −$0.79 | −$1.03 | −$0.52 | −$0.67 | −$0.67 | −$0.71 | −$0.76 | |
| 111 | 110 | 84 | 84 | 84 | 73 | 62 | 55 |
Trend